Related Experiment Video
Updated: Jul 28, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness
C D Marchant1, A M Loughlin, S M Lett
1Massachusetts Public Health Biologic Laboratory, Massachusetts Centers for Disease Control, Boston.
Insights
Massachusetts pertussis surveillance shows infants under 6 months face high risks. Vaccination status impacts pertussis (whooping cough) incidence in children and adolescents. Serodiagnosis improves detection in older populations.
Area of Science:
- Epidemiology
- Immunology
- Public Health
Background:
- Massachusetts has monitored pertussis (whooping cough) incidence using a statewide diagnostic service since 1980.
- Diphtheria-tetanus toxoid-pertussis (DTP) vaccination is provided, yet pertussis remains a concern.
Purpose of the Study:
- To analyze pertussis incidence and morbidity trends in Massachusetts.
- To evaluate the impact of DTP vaccination on pertussis cases.
- To assess the utility of serodiagnosis for detecting pertussis in different age groups.
Main Methods:
- Analysis of bacteriologically confirmed pertussis cases and hospitalizations from a statewide diagnostic service.
- Review of DTP vaccination histories for individuals diagnosed with pertussis.
- Serodiagnostic testing using single serum anti-pertussis toxin antibody ELISA for population-based diagnosis.
Main Results:
- Infants under 6 months experienced disproportionately high morbidity, accounting for 44% of confirmed cases and 71% of hospital days.
- Most children with pertussis had received fewer than 3 DTP doses, while adolescents often had received 4 or more doses.
- Serodiagnosis significantly increased the detected incidence of pertussis in adolescents and adults.
Conclusions:
- Bacteriologic methods likely underestimate the true incidence of pertussis.
- Infants < 6 months are a vulnerable population requiring targeted prevention strategies.
- Single serum anti-pertussis toxin antibody ELISA is a practical and effective method for diagnosing pertussis in adolescents and adults.
Abstract:
Massachusetts provides diphtheria-tetanus toxoid-pertussis (DTP) vaccine, and since 1980 has monitored pertussis with a statewide diagnostic service. The incidence of bacteriologically confirmed pertussis was 104.5 per 100,000 person-years in 1-month-old infants and declined progressively thereafter. Infants < 6 months old experienced disproportionate morbidity: 44% of bacteriologically confirmed pertussis, 64% of hospitalizations, and 71% of hospital days. Most children with pertussis had received < 3 DTP doses during childhood, whereas 87% of adolescents with pertussis had received > or = 4 doses. Serodiagnosis by single serum anti-pertussis toxin antibody ELISA increased the incidence of confirmed pertussis in persons 11-19 years old from 3.0 to 12.9 per 100,000 and in persons > or = 20 years old from 0.16 to 0.56 per 100,000. Bacteriologic methods underestimate pertussis incidence, but a single serum anti-pertussis toxin antibody ELISA is a practical method for population-based diagnosis in adolescents and adults.
Related Concept Videos
Vaccinations
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Investigation of Disease Outbreaks
Diphtheria
Smallpox
Poliomyelitis

